Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TH5H
|
|||
| Drug Name |
Dapansutrile
|
|||
| Synonyms |
54863-37-5; OLT1177; UNII-2Z03364G96; 2Z03364G96; Dapansutrile [INN]; Dapansutrile [USAN:INN]; Dapansutrile (USAN/INN); 3-Methylsulfonylpropionitrile; 3-methanesulfonylpropanenitrile; 3-methylsulphonyl-propionitrile; SCHEMBL9934796; CHEMBL3989943; LQFRYKBDZNPJSW-UHFFFAOYSA-N; MolPort-008-545-498; ZINC32005410; Propanenitrile, 3-(methylsulfonyl)-; AKOS010140086; D10920; Z2719319073
Click to Show/Hide
|
|||
| Indication | Acute gout flare [ICD-11: FA25.0; ICD-10: M10.0; ICD-9: 274] | Phase 2 | [1] | |
| Musculoskeletal pain [ICD-11: MG30; ICD-10: R07.3; ICD-9: 338,780] | Phase 2 | [1] | ||
| Company |
Olatec Therapeutics New York, NY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H7NO2S
|
|||
| Canonical SMILES |
CS(=O)(=O)CCC#N
|
|||
| InChI |
1S/C4H7NO2S/c1-8(6,7)4-2-3-5/h2,4H2,1H3
|
|||
| InChIKey |
LQFRYKBDZNPJSW-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 54863-37-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Caterpiller protein 1.1 (NLRP3) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.